Biogen Inc (Biogen) is a global biotechnology company that specializes in discovering and developing products that address medical needs in the fields of oncology, neurology, and immunology. Focus on R&D, increase in revenue from biosimilars products, and geographical presence are the major strengths of the company, even as decline in operating income and discontinued programs could be an area of concern. Business initiatives, strategic collaborations, and growing incidence of MS could create new revenue generating opportunities for the company. However, competitive pressures, stringent government regulations, and uncertain R&D outcomes could affect its operations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer